Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 2;9(1):3038.
doi: 10.1038/s41467-018-05441-9.

Cysteine-mediated decyanation of vitamin B12 by the predicted membrane transporter BtuM

Affiliations

Cysteine-mediated decyanation of vitamin B12 by the predicted membrane transporter BtuM

S Rempel et al. Nat Commun. .

Abstract

Uptake of vitamin B12 is essential for many prokaryotes, but in most cases the membrane proteins involved are yet to be identified. We present the biochemical characterization and high-resolution crystal structure of BtuM, a predicted bacterial vitamin B12 uptake system. BtuM binds vitamin B12 in its base-off conformation, with a cysteine residue as axial ligand of the corrin cobalt ion. Spectroscopic analysis indicates that the unusual thiolate coordination allows for decyanation of vitamin B12. Chemical modification of the substrate is a property other characterized vitamin B12-transport proteins do not exhibit.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Function and structure of BtuMTd. a Schematic representation of cobalamin (Cbl) showing the corrinoid ring with the central cobalt ion (red). The ligand at the β-axial position is in this case a cyano-group, but differs in various Cbl variants (Supplementary Figure 1a, b). The ligand at the α-axial position (base-on conformation) is the 5,6-dimethylbenzimidazole base, which is covalently linked to the corrinoid ring. When this coordination is lost, Cbl is termed base-off. Cbi lacks the 5,6-dimethylbenzimidazole base (indicated by the zigzagged red line). b Growth assays with E. coli ΔFEC was conducted in the presence of 50 μg ml−1 l-methionine or 1 nM Cbl. Additional experiments in the presence of different Cbl concentration are shown in Supplementary Figure 2f and g. All growth curves are averages of nine experiments (three biological triplicates, each with three technical replicates). Top panel: cells containing the empty expression vector (pBAD24) in the presence of methionine (blue line) or Cbl (grey line) and cells expressing the BtuCDF system (black and red lines, respectively). Bottom panel: cells expressing BtuMTd (black and red lines) or mutant BtuMTd_C80S (blue and grey) in the presence of methionine and Cbl, respectively. The inset displays a western blot showing that the mutant is expressed to wild-type levels (the full-length western blot can be found in Supplementary Figure 2h). c The structure of BtuMTd in cartoon representation, coloured from blue (N terminus) to red (C terminus) and viewed from the membrane plane. α-helices (H1-6) and connecting loops (L1-5) are indicated. Cbl is shown in stick representation with carbon atoms coloured wheat, the oxygen and nitrogen atoms in red and blue, respectively, the cobalt ion in pink. Four n-nonyl-β-d-glucopyranoside detergent molecules are also shown in stick representation (carbons in light grey)
Fig. 2
Fig. 2
Binding of vitamin B12 by BtuMTd. a Transparent surface representation (light grey) of the binding pocket of BtuMTd with bound Cbl. The protein backbone is shown in blue. The Co-ion is coordinated by Cys80 located in L3 (Co to sulphur distance 2.7 Å) and His207 (Co to nitrogen distance 2.4 Å) from a neighbouring symmetry mate (Supplementary Figure 6). A complete description of the interactions of BtuMTd with its substrate can be found in Supplementary Figure 12. b The spectrum of BtuMTd_cHis8-bound Cbl (4.3 μM, black line) compared to unbound cyano-Cbl (2.4 μM, red line). The regions of the spectrum with major changes are indicated with arrows. c Same as b but with Cbi bound to the protein (9.2 μM black line), compared to unbound dicyano-Cbi (9 μM, red line). The regions of the spectrum with major changes are indicated with arrows. For comparison, a scaled spectrum of Cbl bound to BtuMTd (light grey line) from b is included, showing that the spectrum of both substrates bound to the protein is virtually the same, indicating the same binding mode
Fig. 3
Fig. 3
Cobinamide (Cbi) binding to BtuMTd and BtuMTd-catalysed decyanation. a Representative ITC-measurements of differently tagged BtuMTd constructs. BtuMTd with a C-terminal His-tag binds Cbi with a Kd value of 0.65 ± 0.27 μM (top). EPEA-tagged BtuMTd binds Cbi with essentially the same affinity of Kd 0.58 ± 0.13 μM (middle). For the EPEA-tagged mutant version BtuMTd_C80S Kd = 5.6 ± 2.8 μM (bottom). All ITC experiments were performed as technical triplicates, error is s.d. b Decyanation of Cbi catalysed by EPEA-tagged BtuMTd. Upon addition of an excess of BtuMTd to Cbi, the substrate is slowly decyanated, which can be followed spectroscopically (left) with the main spectral changes indicated by the arrows. The mutant BtuMTd_C80S, did not catalyse decyanation (right). c Quantification (error bars are s.d. of technical triplicates) of decyanation reveals that the process is slow. The ratio of the absorption at 369 nm over 330 nm of BtuMTd (black dots) was plotted as function of time. A mono-exponential decay function was fitted to the data (red line) to extract τ = 12 ± 0.7 min (s.d. of technical triplicates), which is comparable to the decyanation rate of the His-tagged protein and the process follows pseudo-first order kinetics (Supplementary Figure 8b, c). The ratio of absorption obtained with the cysteine mutant (open dots), which does not catalyse decyanation, is shown for comparison

Similar articles

Cited by

References

    1. Gruber K, Puffer B, Kräutler B. Vitamin B12-derivatives—enzyme cofactors and ligands of proteins and nucleic acids. Chem. Soc. Rev. 2011;40:4346. doi: 10.1039/c1cs15118e. - DOI - PubMed
    1. Raux E, Schubert HL, Warren MJ. Biosynthesis of cobalamin (vitamin B12): a bacterial conundrum. Cell. Mol. Life Sci. 2000;57:1880–1893. doi: 10.1007/PL00000670. - DOI - PMC - PubMed
    1. Banerjee RV, Johnston NL, Sobeski JK, Datta P, Matthews RG. Cloning and sequence analysis of the Escherichia coli metH gene encoding cobalamin-dependent methionine synthase and isolation of a tryptic fragment containing the cobalamin-binding domain. J. Biol. Chem. 1989;264:13888–13895. - PubMed
    1. Martens JH, Barg H, Warren M, Jahn D. Microbial production of vitamin B12. Appl. Microbiol. Biotechnol. 2002;58:275–285. doi: 10.1007/s00253-001-0902-7. - DOI - PubMed
    1. Rodionov DA, Vitreschak AG, Mironov AA, Gelfand MS. Comparative genomics of the vitamin B12 metabolism and regulation in prokaryotes. J. Biol. Chem. 2003;278:41148–41159. doi: 10.1074/jbc.M305837200. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources